ArticlePLoS medicine2008
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.
Article in PLoS medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.
- The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.Cancer causes & control : CCC · 2012Pooled it
- Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.PLoS medicine · 2012Pooled it
- Obesity and Lifestyle Drift: Framing Analysis of Calorie Menu Labelling in England in News Media.International journal of health policy and management · 2025Article
- Association between tobacco exposure and bladder cancer recurrence: A systematic review and meta-analysis.World journal of methodology · 2024Article
- Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy.International journal of health policy and management · 2023Article
- Analysis of British American Tobacco's questionable use of privilege and protected document claims at the Guildford Depository.Tobacco control · 2017Article
- Unpacking commercial sector opposition to European smoke-free policy: lack of unity, 'fear of association' and harm reduction debates.Tobacco control · 2016Article
- 'Public enemy no. 1': Tobacco industry funding for the AIDS response.SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2016Review
- Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda.Palgrave communications · 2016Article
- Challenges for philanthropy and tobacco control in China (1986-2012).Tobacco control · 2013Article
- The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.Journal of business ethics : JBE · 2013Article
- Article
- British American Tobacco's partnership with Earthwatch Europe and its implications for public health.Global public health · 2012Review
- Relationship between the Chinese tobacco industry and academic institutions in China.Tobacco control · 2011Article
- Globe still in grip of addiction.Nature · 2010Article
- Home smoking bans in an urbanizing community in China.American journal of preventive medicine · 2009Article
- Lessons learned on the road to a smoke-free Italy.Annali di igiene : medicina preventiva e di comunitaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 2 countries.
Funding
Abstract
backgroundEach year, 540 million Chinese are exposed to secondhand smoke (SHS), resulting in more than 100,000 deaths. Smoke-free policies have been demonstrated to decrease overall cigarette consumption, encourage smokers to quit, and protect the health of nonsmokers. However, restrictions on smoking in China remain limited and ineffective. Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countries. METHODS AND
findingsTo understand company activities in China related to SHS, we analyzed British American Tobacco's (BAT's) internal corporate documents produced in response to litigation against the major cigarette manufacturers to understand company activities in China related to SHS. BAT has carried out an extensive strategy to undermine the health policy agenda on SHS in China by attempting to divert public attention from SHS issues towards liver disease prevention, pushing the so-called "resocialisation of smoking" accommodation principles, and providing "training" for industry, public officials, and the media based on BAT's corporate agenda that SHS is an insignificant contributor to the larger issue of air pollution.
conclusionsThe public health community in China should be aware of the tactics previously used by TTCs, including efforts by the tobacco industry to co-opt prominent Chinese benevolent organizations, when seeking to enact stronger restrictions on smoking in public places.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.